세계의 OTC 진통제 시장 : 약제 유형별, 투여 경로별, 유통 채널별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

REPORT HIGHLIGHT

Over-the-Counter (OTC) Pain Medication Market size was valued at US$ 28,942.6 Million in 2024, expanding at a CAGR of 4.20% from 2025 to 2032.

Over-the-counter (OTC) medications are those that licensed pharmacists dispense without a prescription. Whether at home or work, people frequently turn to over-the-counter (OTC) pain medications to relieve even the smallest physical discomfort. Both generic and brand-name OTC pain relievers come in tablet, pill, cream, ointment, spray, and patch form. The most widely used over-the-counter painkiller, paracetamol, has no anti-inflammatory properties. In the central nervous system (CNS), paracetamol inhibits the production of prostaglandins. The first line of treatment for acute lower back pain has been suggested to be acetaminophen. Over the past few years, the market for over-the-counter painkillers has shown encouraging trends. OTC painkiller demand has been mostly driven by the world's growing population as well as the ageing population that is more susceptible to arthritis and joint pain.

Furthermore, people are experiencing increased headaches, back pain, and muscle aches as a result of elevated stress levels brought on by changing lifestyles and busy schedules. As a result, the tendency to self-medicate without prescription medications has grown. In addition, consumer confidence in over-the-counter medicines has increased due to formulation innovations that decrease dosage frequency and increase product effectiveness. In the upcoming years, the market's growth may be constrained by the availability of substitute treatment options and rising awareness of the negative effects of painkillers.

Over-the-Counter (OTC) Pain Medication Market- Market Dynamics

Increasing frequency of chronic illnesses worldwide

The market for over-the-counter (OTC) pain medications has grown dramatically as a result of the increasing frequency of chronic illnesses worldwide. The number of chronic conditions like arthritis, back pain, migraines, and headaches that need long-term pain management has been steadily increasing. Nearly 60% of people worldwide are thought to experience chronic pain issues. The likelihood of chronic pain is increased by the prevalence of age-related physical impairments brought on by longer lifespans. An ageing workforce, busy lives, an excessive workload, and a lack of physical activity are also exacerbating the issue. Because over-the-counter (OTC) drugs are readily available, reasonably priced, and do not require a prescription, people with chronic pain frequently turn to them for either episodic or long-term relief. The demand for well-known goods that comprise ibuprofen, acetaminophen, and topical gels and creams has increased, according to pharmacies. Even while prescription painkillers are also commonly used, OTC medications are becoming a more appealing option due to worries about addiction, tolerance, and adverse effects. Additionally, in order to prevent the overprescription of opioids or other restricted narcotics, doctors advise OTC pharmaceuticals as the initial therapeutic option for mild to moderate pain. Over-the-counter (OTC) drugs are expected to be used more frequently for pain treatment as chronic illnesses become more prevalent globally.

Over-the-Counter (OTC) Pain Medication Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.20% over the forecast period (2025-2032)

Based on drug type segmentation, the nonsteroidal anti-inflammatory drug category was predicted to show maximum market share in the year 2024

Based on distribution channel segmentation, hospital pharmacies were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Over-the-Counter (OTC) Pain Medication Market- Segmentation Analysis:

The Global Over-the-Counter (OTC) Pain Medication Market is segmented on the basis of Drug Type, Route of Administration, Distribution Channel, and Region.

Based on drug type, the market is divided into Acetaminophen, Nonsteroidal Anti-inflammatory Drug, and Others. In 2024, the nonsteroidal anti-inflammatory drug category held a dominant market share because of the high cases of pain-related disorders in the world's ageing population. NSAIDs are frequently used to alleviate backaches, joint and muscular discomfort, and swollen or damaged body parts that older adults frequently report. According to demographic trends, the number of people 65 and older will rise dramatically over the next several decades in both developed and developing countries as life expectancies rise. As people age, chronic pain also becomes increasingly common. NSAIDs are now commonplace in many homes and medicine cabinets due to the sizable and growing number of senior citizens who rely on over-the-counter drugs for pain management. Their extensive availability boosts their popularity for self-medication of age-related discomforts without a prescription and their demonstrated efficacy.

On the basis of the route of administration, the market is segregated into Topical, Oral, and Parenteral. In 2024, the market was dominated by the oral category. This is because, particularly for sporadic or intermittent pain, oral pills are the most practical and simplest way for people to self-administer over-the-counter pharmaceuticals. Pain treatment without the inconvenience of applying creams or gels is possible anywhere by swallowing tablets or capsules. Oral formulations, such as tablets and liquids, are now the most popular option for self-treatments due to this important benefit. Being user-friendly "on the go" is crucial for energetic, busy consumers who can have headaches or mild strained muscles while out and about. Customers can feel more secure about the safety and efficacy of oral medications because they have undergone more thorough research and testing than topical preparations.

Over-the-Counter (OTC) Pain Medication Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Over-the-Counter (OTC) Pain Medication. The demand for over-the-counter (OTC) pain medications is fueled by the region's established healthcare system and high level of consumer health awareness. The ageing population and the cases of chronic pain problems also influence sustained consumption. Strong pharmaceutical laws promote consumer trust by guaranteeing the quality and safety of products. Manufacturers' intensive marketing and advertising campaigns also increase consumption. Furthermore, North America's dominant position in the over-the-counter (OTC) pain medications industry is reinforced by the existence of well-known pharmaceutical businesses and the extensive availability of OTC goods in retail establishments.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The market for over-the-counter (OTC) pain medications is expected to develop significantly in the Asia-Pacific region mainly because of its large population, growing middle class, and rising purchasing power. The demand for over-the-counter (OTC) pain medications has increased as a result of significant increases in disposable income and urbanization in nations like China and India. Additionally, a cultural propensity for self-medication and the prevalence of common illnesses have accelerated market growth. Pharmaceutical companies are focusing on this market and introducing a range of over-the-counter (OTC) painkillers to cater to the expanding consumer base.

Over-the-Counter (OTC) Pain Medication Market- Competitive Landscape:

Many multinational pharmaceutical companies, including Johnson & Johnson, Pfizer Inc., Sanofi S.A., Reckitt Benckiser Group plc, Bayer AG, GlaxoSmithKline plc, and others, dominate the competitive environment of the over-the-counter (OTC) pain medications market. Branded and generic labels are important as well since they provide affordable substitutes. The market placement of analgesic formulations, such as salicylate, acetaminophen, and NSAIDs, is influenced by marketing strategies, product innovations, and regulatory factors. Global market trends, consumer preferences, and distribution strategies influence Over-the-counter (OTC) pain medications competition. Businesses are attempting to put some important measures into place in order to get a competitive advantage. For instance, in October 2023, Belgium-based Hyloris Pharmaceuticals announced that the USFDA had approved the potent non-opioid pain reliever Maxigesic IV. Developed in partnership with AFT Pharmaceuticals, Maxigesic IV is designed to be used as an adjuvant for mild-to-moderate pain and moderate-to-severe pain. This postoperative infusion, which combines 300 mg of ibuprofen and 1,000 mg of paracetamol, offers an alternative to narcotic drugs.

Recent Development

March 2024: Certain over-the-counter topical analgesics have been cautioned by the U.S. FDA not to be used for pain relief prior to, during, or following cosmetic procedures such as laser hair removal, tattooing, piercing, and microdermabrasion. Six businesses received warning letters from the government for unlawfully promoting these goods.

January 2023: Natural Pain Relief capsules are Medterra's newest offering. A professionally validated plant-based pain reliever, Medterra Natural Pain Relief is designed to reduce inflammation, joint stiffness, and muscular discomfort without the unfavourable side effects that are frequently connected to over-the-counter (OTC) alternatives.

August 2022: The biopharmaceutical business Myovant Sciences and Pfizer announced that MYFEMBREE (relugolix, estradiol, and norethindrone acetate) was approved by the USFDA as a once-daily pill for the treatment of moderate to severe endometriosis pain in premenopausal women. The medication can be taken for up to 24 months. The clearance also covers treatment for excessive menstrual bleeding caused by uterine fibroids, and it is backed by evidence from an open-label extension study and Phase 3 trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OVER-THE-COUNTER (OTC) PAIN MEDICATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Johnson & Johnson
• Pfizer Inc.
• Sanofi S.A.
• Reckitt Benckiser Group plc
• Bayer AG
• GlaxoSmithKline plc
• Novartis AG
• Perrigo Company plc
• Takeda Pharmaceutical Company Limited
• Lupin Limited
• Sun Pharmaceutical Industries Ltd.
• Alkem Laboratories Ltd.
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Glenmark Pharmaceuticals Ltd.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Others

GLOBAL OVER-THE-COUNTER (OTC) PAIN MEDICATION MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

• Acetaminophen
• Nonsteroidal Anti-inflammatory Drug
• Others

GLOBAL OVER-THE-COUNTER (OTC) PAIN MEDICATION MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

• Topical
• Oral
• Parenteral

GLOBAL OVER-THE-COUNTER (OTC) PAIN MEDICATION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

• Hospital Pharmacies
• E-commerce
• Retail Pharmacies
• Home Care
• Others

GLOBAL OVER-THE-COUNTER (OTC) PAIN MEDICATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Over-the-Counter (OTC) Pain Medication Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Over-the-Counter (OTC) Pain Medication Market Snippet by Drug Type
  • 2.1.2. Over-the-Counter (OTC) Pain Medication Market Snippet by Route of Administration
  • 2.1.3. Over-the-Counter (OTC) Pain Medication Market Snippet by Distribution Channel
  • 2.1.4. Over-the-Counter (OTC) Pain Medication Market Snippet by Country
  • 2.1.5. Over-the-Counter (OTC) Pain Medication Market Snippet by Region
• 2.2. Competitive Insights

3. Over-the-Counter (OTC) Pain Medication Key Market Trends

• 3.1. Over-the-Counter (OTC) Pain Medication Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Over-the-Counter (OTC) Pain Medication Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Over-the-Counter (OTC) Pain Medication Market Opportunities
• 3.4. Over-the-Counter (OTC) Pain Medication Market Future Trends

4. Over-the-Counter (OTC) Pain Medication Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Over-the-Counter (OTC) Pain Medication Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Over-the-Counter (OTC) Pain Medication Market Landscape

• 6.1. Over-the-Counter (OTC) Pain Medication Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Over-the-Counter (OTC) Pain Medication Market - By Drug Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Drug Type, 2024 & 2032 (%)
  • 7.1.2. Acetaminophen
  • 7.1.3. Nonsteroidal Anti-inflammatory Drug
  • 7.1.4. Others

8. Over-the-Counter (OTC) Pain Medication Market - By Route of Administration

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
  • 8.1.2. Topical
  • 8.1.3. Oral
  • 8.1.4. Parenteral

9. Over-the-Counter (OTC) Pain Medication Market - By Distribution Channel

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
  • 9.1.2. Hospital Pharmacies
  • 9.1.3. E-commerce
  • 9.1.4. Retail Pharmacies
  • 9.1.5. Home Care
  • 9.1.6. Others

10. Over-the-Counter (OTC) Pain Medication Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Over-the-Counter (OTC) Pain Medication Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Over-the-Counter (OTC) Pain Medication Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.8. France
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.9. Italy
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.10. Spain
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.11. United Kingdom
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.11.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.12. Russia
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.13. Netherlands
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.14. Sweden
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Over-the-Counter (OTC) Pain Medication Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.9. South Korea
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.10. Japan
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Over-the-Counter (OTC) Pain Medication Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Over-the-Counter (OTC) Pain Medication Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Over-the-Counter (OTC) Pain Medication Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Johnson & Johnson
  • 11.2.2. Pfizer Inc.
  • 11.2.3. Sanofi S.A.
  • 11.2.4. Reckitt Benckiser Group plc
  • 11.2.5. Bayer AG
  • 11.2.6. GlaxoSmithKline plc
  • 11.2.7. Novartis AG
  • 11.2.8. Perrigo Company plc
  • 11.2.9. Takeda Pharmaceutical Company Limited
  • 11.2.10. Lupin Limited
  • 11.2.11. Sun Pharmaceutical Industries Ltd.
  • 11.2.12. Alkem Laboratories Ltd.
  • 11.2.13. Cipla Ltd.
  • 11.2.14. Dr. Reddy's Laboratories Ltd.
  • 11.2.15. Glenmark Pharmaceuticals Ltd.
  • 11.2.16. Teva Pharmaceutical Industries Ltd.
  • 11.2.17. Boehringer Ingelheim International GmbH
  • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us